Figure 3
From: Preclinical immunotherapy with Cytokine-Induced Killer lymphocytes against epithelial ovarian cancer
In vitro activity of CIK against chemo-surviving pdOVC. (A) CIK are capable of killing residual pdOVC that survived therapeutic doses (IC50, 72 hours) of carboplatin in vitro. CIK cytotoxicity is fully comparable, with a trend to superiority, with paired control against untreated pdOVC. (B) Tumor killing was evaluated by flow cytometry. The figure shows representative flow-cytometry dot plots reporting the decrease of viable tumor cells during treatment with CIK.
